Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año20152016201720182019202020212022202320242025 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialExpression of ConcernLetterProceedings PaperReprintReview Revista Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis. Autores: Rodríguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Gracia-Gil J, Fernández E, Meca-Lallana V, Díaz-Pérez C, Sainz de la Maza S, Pacheco EM, Quiroga A, Ramió-Torrentà L, Martínez-Yélamos S, Bau L, Monreal E, López-Real A, Rodero-Romero A, Borrega L, Díaz S, Eguía P, Espiño M, Chico-García JL, Barrero FJ, Martínez-Ginés ML, García-Domínguez JM, De la Fuente S, Moreno I, Sainz-Amo R, Mañé-Martínez MA, Caminero A, Castellanos F, Gómez López A, Labiano-Fontcuberta A, Ayuso L, Abreu R, Hernández MÁ, Meca-Lallana J, Martín-Aguilar L, Muriel García A, Masjuan J, Costa-Frossard L, Villar LM Adolescent alcohol exposure modifies adult anxiety-like behavior and amygdala sensitivity to alcohol in rats: Increased c-Fos activity and sex-dependent microRNA-182 expression Autores: Vázquez-Agredos, A; Valero, M; Aparicio-Mescua, T; García-Rodríguez, R; Gámiz, F; Gallo, M Emerging Topics in Metal Complexes: Pharmacological Activity Autores: Scibior, A; Aureliano, M; Llopis, J Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation Autores: Sanmartino, F; Cano-Cano, F; Rashid-López, R; Cruz-Gómez, AJ; Lozano-Soto, E; Macias-García, P; Sánchez-Fernández, FL; López-Sosa, F; Gómez-Jaramillo, L; Riqué-Dormido, J; Escamilla-Sevilla, F; Espinosa-Rosso, R; González-Rosa, JJ Bioactive Properties of Tagetes erecta Edible Flowers: Polyphenol and Antioxidant Characterization and Therapeutic Activity against Ovarian Tumoral Cells and Caenorhabditis elegans Tauopathy Autores: Rivas-García, L; Crespo-Antolín, L; Forbes-Hernández, TY; Romero-Márquez, JM; Navarro-Hortal, MD; Arredondo, M; Llopis, J; Quiles, JL; Sánchez-González, C Dopamine Pathway and Parkinson’s Risk Variants Are Associated with Levodopa-Induced Dyskinesia Autores: Sosero, YL; Bandres-Ciga, S; Ferwerda, B; Tocino, MTP; Belloso, DR; Gómez-Garre, P; Faouzi, J; Taba, P; Pavelka, L; Marques, TM; Gomes, CPC; Kolodkin, A; May, P; Milanowski, LM; Wszolek, ZK; Uitti, RJ; Heutink, P; van Hilten, JJ; Simon, DK; Eberly, S; Alvarez, I; Krohn, L; Yu, E; Freeman, K; Rudakou, U; Ruskey, JA; Asayesh, F; Menendez-Gonzalez, M; Pastor, P; Ross, OA; Krueger, R; Corvol, JC; Koks, S; Mir, P; De Bie, RMA; Iwaki, H; Gan-Or, Z Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson’s Disease Risk at this Locus? Autores: Lázaro-Figueroa, A; Hernández-Medrano, AJ; Ramírez-Pineda, DB; Cadavid, AN; Makarious, M; Foo, JN; Alvarado, CX; Bandres-Ciga, S; Periñan, MT < 1 2 … 311 312 313 … 1.706 1.707 >